Vial sharing assumption showed a 9% (95% CI, 2.5%–15.5%) reduction in cost in one year.doi:10.1111/bcp.14064MG GopisankarDepartment of Pharmacology NEIGRIHMS IndiaJulie WahlangDepartment of Pharmacology NEIGRIHMS IndiaVikas JagtapDepartment of Radiation Oncology NEIGRIHMS IndiaChayna Sarkar...
Cancer treatments have improved outcomes but access to medications is an issue around the world and especially so in low- and middle-income countries, such as India. Generic substitution may lead to significant cost savings. The author aimed to compare the cost and estimate potential cost savings...
Lopes, G. Cost comparison and economic implications of commonly used originator and generic chemotherapy drugs in India. Ann. Oncol. 2013, 24, v13-v16.Lopes Gde L. Cost comparison and economic implications of commonly used originator and generic chemotherapy drugs in India. Ann Oncol 2013;24 ...
weather. Cost depends on the country you belong to. The natural products are also prepared according to the diagnosis and types of alopecia. The cost includes 6 months of natural products with shipment charges. Refer to the link for cost of the treatments. https://www.alopeciacure.com/cost...
Maheshwari A (2014) Cost effectiveness of treatment of guillain barre syndrome with iv immunoglobulins versus plasmapharesis [MD thesis]. PGIMER, Chandigarh Sangwan A (2015) Cost of trauma care in secondary and tertiary care public sector hospitals in north india [MPH thesis]. PGIMER, Chandigarh...
According to the article published in the National Library of Medicine in February 2021, colon cancer patients reported cost savings of around USD 1,513.37 per patient for the entire course of chemotherapy at home in Thailand. Some pharmacy providers are encouraging patients and service providers to...
The Efficacy, Safety, and Cost Benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study from South India Govind Babu,Smitha Carol Saldanha,Lakshmaiah Kuntegowdanahalli Chinnagiriyappa,Linu Abraham Jacob,Suresh Babu Mallekavu,Loknatha Dasappa…See all authors ...
Acta Med Costarne 10:235–255 Google Scholar Chabaud AG (1972) Description de Stefanskostrongylus dubosti n. sp. parasite du potoma- jole et essai de classification des nématodes Angiostrongylinae. Ann Parasitol Hum Comp 47:735–744 PubMed CAS Google Scholar Chabaud AG, Lariviere M (...
According to the current guidelines, the prophylactic use of G-CSF should be based on the evaluation of patients' overall risk for FN by two components: type of chemotherapy regimens1,18 and patient-related factors.18 Besides, factors like cost and paucity of conclusive studies showing efficacy ...
Achievement of a pCR using dual HER2 blockade in the neoadjuvant setting carries additional value for patients in low- and middle-income countries. A major impediment to the utilization of P + H based therapy in India is the cost associated with these agents, since few individuals have health ...